CARLIN GOLD CORPORATION (CGD.CA) Fundamental Analysis & Valuation

TSX-V:CGD • CA1422402091

Current stock price

0.3 CAD
+0.02 (+7.14%)
Last:

This CGD.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. CGD.CA Profitability Analysis

1.1 Basic Checks

  • CGD had positive earnings in the past year.
  • In the past year CGD has reported a negative cash flow from operations.
CGD.CA Yearly Net Income VS EBIT VS OCF VS FCFCGD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 200K -200K 400K

1.2 Ratios

  • CGD's Return On Assets of 12.03% is amongst the best of the industry. CGD outperforms 92.96% of its industry peers.
  • Looking at the Return On Equity, with a value of 12.09%, CGD belongs to the top of the industry, outperforming 90.69% of the companies in the same industry.
Industry RankSector Rank
ROA 12.03%
ROE 12.09%
ROIC N/A
ROA(3y)7.89%
ROA(5y)N/A
ROE(3y)9.61%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CGD.CA Yearly ROA, ROE, ROICCGD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for CGD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CGD.CA Yearly Profit, Operating, Gross MarginsCGD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

9

2. CGD.CA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for CGD remains at a similar level compared to 1 year ago.
  • CGD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CGD.CA Yearly Shares OutstandingCGD.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
CGD.CA Yearly Total Debt VS Total AssetsCGD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1M 2M 3M

2.2 Solvency

  • CGD has an Altman-Z score of 172.31. This indicates that CGD is financially healthy and has little risk of bankruptcy at the moment.
  • CGD's Altman-Z score of 172.31 is amongst the best of the industry. CGD outperforms 93.96% of its industry peers.
  • CGD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 172.31
ROIC/WACCN/A
WACCN/A
CGD.CA Yearly LT Debt VS Equity VS FCFCGD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 1M 2M 3M

2.3 Liquidity

  • CGD has a Current Ratio of 113.00. This indicates that CGD is financially healthy and has no problem in meeting its short term obligations.
  • CGD's Current ratio of 113.00 is amongst the best of the industry. CGD outperforms 99.12% of its industry peers.
  • CGD has a Quick Ratio of 113.00. This indicates that CGD is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of CGD (113.00) is better than 99.12% of its industry peers.
Industry RankSector Rank
Current Ratio 113
Quick Ratio 113
CGD.CA Yearly Current Assets VS Current LiabilitesCGD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500K 1M 1.5M

1

3. CGD.CA Growth Analysis

3.1 Past

  • CGD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 643.02%, which is quite impressive.
EPS 1Y (TTM)643.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. CGD.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 6.00, the valuation of CGD can be described as very cheap.
  • Compared to the rest of the industry, the Price/Earnings ratio of CGD indicates a rather cheap valuation: CGD is cheaper than 97.11% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of CGD to the average of the S&P500 Index (24.89), we can say CGD is valued rather cheaply.
Industry RankSector Rank
PE 6
Fwd PE N/A
CGD.CA Price Earnings VS Forward Price EarningsCGD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CGD.CA Per share dataCGD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. CGD.CA Dividend Analysis

5.1 Amount

  • CGD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CGD.CA Fundamentals: All Metrics, Ratios and Statistics

CARLIN GOLD CORPORATION

TSX-V:CGD (3/27/2026, 7:00:00 PM)

0.3

+0.02 (+7.14%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners31.08%
Ins Owner ChangeN/A
Market Cap5.80M
Revenue(TTM)N/A
Net Income(TTM)553.50K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.27
P/tB 1.27
EV/EBITDA N/A
EPS(TTM)0.05
EY16.67%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.24
TBVpS0.24
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.52
Profitability
Industry RankSector Rank
ROA 12.03%
ROE 12.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)7.89%
ROA(5y)N/A
ROE(3y)9.61%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 113
Quick Ratio 113
Altman-Z 172.31
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)643.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y50.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y9.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.39%
OCF growth 3YN/A
OCF growth 5YN/A

CARLIN GOLD CORPORATION / CGD.CA Fundamental Analysis FAQ

What is the fundamental rating for CGD stock?

ChartMill assigns a fundamental rating of 4 / 10 to CGD.CA.


What is the valuation status for CGD stock?

ChartMill assigns a valuation rating of 2 / 10 to CARLIN GOLD CORPORATION (CGD.CA). This can be considered as Overvalued.


Can you provide the profitability details for CARLIN GOLD CORPORATION?

CARLIN GOLD CORPORATION (CGD.CA) has a profitability rating of 2 / 10.


How financially healthy is CARLIN GOLD CORPORATION?

The financial health rating of CARLIN GOLD CORPORATION (CGD.CA) is 9 / 10.